Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis.
Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
Tuon
Felipe Francisco
FF
Department of Infectious Diseases, University of São Paulo, Medical School, São Paulo, SP, Brazil. ffbt@pop.com.br
Guastini
Cristina Maria de Fátima
CM
Boulos
Maria Ivete Castro
MI
D000208:Acute Disease; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D034321:Hyperamylasemia / Q000139:chemically induced*; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced* / Q000201:enzymology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine